Original article by John Stensholt
The Australian Financial Review – Page: 29 : 14-May-15
Australian businessman Bruce Mathieson has a 7.46 per cent stake in drug manufacturer Mayne Pharma. The sharp rise in its share price in 2015 has lifted the value of Mathieson’s shareholding to around $A70m. Mayne’s market capitalisation is now almost $A1bn, and Mathieson expects the stock to keep rising. Mathieson is a non-executive director of Mayne.
MAYNE PHARMA GROUP LIMITED – ASX MYX, STANDARD AND POOR’S ASX ALL ORDINARIES INDEX, AUSTRALIAN LEISURE AND HOSPITALITY GROUP LIMITED, WOOLWORTHS LIMITED – ASX WOW, PFD FOOD SERVICES PTY LTD, REECE AUSTRALIA LIMITED – ASX REH, THORNEY INVESTMENTS PTY LTD, FAIRFAX MEDIA LIMITED – ASX FXJ, PFIZER INCORPORATED, WESTERN DESERT RESOURCES LIMITED – ASX WDR